By the time bloating, cramping, or a change in bowel habits sends someone to a doctor, their gut may have already been changing for a year or longer. Symptoms are the gut's way of finally getting loud enough to notice. The quieter changes that came before them, called subclinical, meaning detectable in a lab but not yet felt by the person, can start much earlier.
The clearest evidence comes from a study that followed children genetically at risk for celiac disease from birth. Celiac disease is an autoimmune reaction to gluten that damages the lining of the small intestine. Researchers with the GEMM study, which followed roughly 500 at-risk children over several years, compared the gut bacteria of ten children who eventually developed celiac disease against ten who stayed healthy.[1]
The two groups' gut bacteria looked different starting about 18 months before diagnosis, much earlier than the researchers expected, a shift similar to what happens more generally when gut bacteria stop getting fed the fiber they rely on. Bacteria linked to inflammation increased. Bacteria known to be protective declined. Metabolic activity in the gut shifted too. The children felt nothing unusual during any of it.
Inflammatory bowel disease works on a related but separate logic, not through a fixed pre-diagnosis timeline but through a marker doctors already use to catch trouble early in people who've been diagnosed before. Fecal calprotectin is a protein released by white blood cells when the gut lining is inflamed. In someone with ulcerative colitis or Crohn's disease who feels fine, a calprotectin level under 50 micrograms per gram of stool suggests real remission. A rising level, particularly above 250 micrograms per gram, often shows up before a flare becomes symptomatic enough to notice.[2] The lab result moves first. The stomach pain follows later, if it shows up at all before the next test.
- Rising fecal calprotectin in someone already diagnosed with IBD, ahead of a felt flare
- Research-cohort microbiome shifts in known at-risk groups, like the celiac study above
- Elevated liver enzymes or iron markers on a routine blood panel, before symptoms appear
- Predicting a first-time diagnosis in someone with no known risk factors, from a single stool sample
- Consumer at-home microbiome kits forecasting future disease in a general, non-at-risk population
- Any test claiming to catch "all" subclinical gut issues in one panel
The distinction matters because it separates two very different situations. A parent whose child has a first-degree relative with celiac disease is in a clearly different position than someone browsing a wellness app that promises to detect problems before they start, the same distinction that matters when weighing whether gut imbalance concerns call for testing or just closer attention. The research supporting early detection exists in narrow, well-defined groups, not as a general claim that any gut can be pre-scanned for trouble.
What to do with this
If you or a family member has a first-degree relative with celiac disease, Crohn's, or ulcerative colitis, ask a gastroenterologist directly whether periodic monitoring makes sense before symptoms appear, rather than waiting for a flare to prompt the first test, the same before-you-need-it thinking behind building gut resilience before stress hits. If you're already diagnosed with IBD and in remission, ask specifically about routine fecal calprotectin checks. A result under 50 µg/g is reassuring. A climbing trend across two or more tests is worth a call to your doctor, even if you feel completely normal. If neither applies to you, skip the consumer microbiome kits sold as early-warning systems; they aren't validated for that job. Instead, track something concrete weekly: stool consistency using the Bristol Stool Chart, a standard 7-point scale doctors use to describe stool from hard lumps to watery, plus your general energy level. A shift that holds for two weeks is a better reason to call a doctor than any single day that felt off.
- "Changes in Microbiome That Might Signal Celiac Disease Before It Develops." BeyondCeliac.org, citing the GEMM study. beyondceliac.org
- "Fecal Calprotectin for the Evaluation of Inflammatory Bowel Disease." American Family Physician, 2021. aafp.org
